AstraZeneca Inc. Reports 21% YOY Revenue Growth in Q3 2024 Financials
UK-based pharmaceutical giant AstraZeneca Inc. (AZ, NASDAQ: AZN) has reported its financial performance for the...
BeiGene’s Q3 2024 Results Show 28% YOY Revenue Growth Driven by Brukinsa and Tevimbra
BeiGene Ltd (NASDAQ: BGNE; HKG: 6160; SHA: 688235), a China-based biotech company, has released its...
Bayer AG Posts Modest Q3 Growth with Strong Performance from New Pharmaceuticals
Germany-based Bayer AG (ETR: BAYN) has released its Q3 2024 financial results, reporting a 0.6%...
Sunshine Lake Pharma Inks Licensing Deal with Apollo Therapeutics for APL-18881
China-based Sunshine Lake Pharma Co., Ltd., (HKG: 1558) a member of the HEC Group, has...
Sihuan Pharmaceutical Plans IPO for Xuanzhu Biopharm on Hong Kong Stock Exchange
China’s Sihuan Pharmaceutical Holdings Group Ltd (HKG: 0460) has announced a renewed attempt to spin...
Boehringer Ingelheim Joins MTM Vision Consortium to Advance Diabetes Retinopathy Research
Germany-based pharmaceutical major Boehringer Ingelheim has announced the initiation of a long-term collaboration with the...
J&J MedTech Receives FDA IDE for OTTAVA Robotic Surgical System Trials
US-based Johnson & Johnson MedTech (J&J, NYSE: JNJ) has announced that it has received an...
Zai Lab Ltd Reports 46% YOY Revenue Growth in Q3 2024 Driven by Vygart, Zejula, and Nuzyra
China-based biotech Zai Lab Ltd (NASDAQ: ZLAB; HKG: 9688) has released its Q3 2024 financial...
Legend Biotech’s Q3 Revenue Soars 67% YOY Driven by Carvykti Sales
China-based Legend Biotech Corporation (NASDAQ: LEGN) has announced its financial results for the third quarter...
Canhelp Genomics Partners with Mirxes to Expand Tumor Origin Testing in Southeast Asia
Canhelp Genomics, a Chinese company specializing in oncology-focused molecular diagnostics, has formed a strategic partnership...
Vesalius Therapeutics Partners with GSK for Novel Parkinson’s Disease Treatments
US-based Vesalius Therapeutics has entered into a strategic agreement with UK pharmaceutical giant GSK plc...
Flare Therapeutics and Roche Enter Strategic Collaboration for Oncology Drug Discovery
US-based Flare Therapeutics Inc., a clinical-stage biotech company specializing in cancer therapies through the use...
Schrödinger and Novartis Ink Deal to Accelerate Drug Discovery Candidates
New York-based Schrödinger, Inc. (NASDAQ: SDGR), a leading software provider in accelerating drug discovery, has...
CSPC Pharmaceutical Gains NMPA Approval for Clinical Trial of mRNA Vaccine SYS6026
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced that it has received clinical trial...
NHSA and MoF Announce Medical Insurance Fund Prepayment Initiative to Aid Healthcare Institutions
The National Healthcare Security Administration (NHSA) and the Ministry of Finance (MoF) have jointly issued...
InnoCare Pharma Reports 29.8% Revenue Increase in Q3 2024 Financials
Beijing-based biotech InnoCare Pharma (HKG: 9969; SHA: 688428) has released its financial report for the...
Triton Partners Mulls Acquisition of Germany’s Evotec SE, Shares Soar 22%
Private equity firm Triton Partners is reportedly contemplating the acquisition of Germany-based Evotec SE (NASDAQ:...
GenScript Biotech Expands in Australia with New Sydney Operations and Logistics Center
GenScript Biotech Corporation (HKG: 1548), a leading Chinese biotechnology company, has announced the establishment of...
Leman Biotech Secures Over USD 13.9 Million in Series A Financing for Next-Gen Cancer Immunotherapies
China-based Leman Biotech Co., Ltd. has reportedly completed the first closing of its Series A...
Biocytogen’s First-in-Class B7H3/PTK7 Bispecific ADC Option Exercised by IDEAYA Biosciences
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG: 2315), a China-based biopharmaceutical company, has announced that its...